LEXX
NASD Lexaria Bioscience Corp.$3.32 ↑ +0.00 (+0.00%) Trading Up from the previous close of $3.32, $0.58 below the day’s high of $3.90
- YTD change
- -64.13%
- vs 20-day SMA
- +2.11%
- vs 200-day SMA
- -65.09%
Price ranges
Price & Performance
+2.41 (+264.84%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 98.2% away from all-time highs of $187.50
- LEXX is down 64% since the beginning of the year
- LEXX is down 75% over the past 12 months
- LEXX is down 18% over the past 1 month
- 9% of all LEXX investors are betting against LEXX
LEXX reads neutral: price sits above one of the two key moving averages, the 12-month move is +287.5%.
- Previous minute
- +$0.00
- Last hour
- +$0.00
- Last 5 days
- +7.44%
- vs 8-day SMA
- +6.58%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Lexaria Bioscience Corp. is a biotechnology company, which engages in the provision of active pharmaceutical ingredients through its DehydraTECH drug delivery technology. It operates through the IP licensing segment which generates revenue from customers by licensing its proprietary DehydraTECH technology. The company was founded on December 9, 2004 and is headquartered in Kelowna, Canada.
Competitor comparison
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.